2005
DOI: 10.1242/jcs.01402
|View full text |Cite
|
Sign up to set email alerts
|

Dynamics and interaction of caveolin-1 isoforms with BMP-receptors

Abstract: Caveolae are small invaginations of the cell membrane that are thought to play a role in important physiological functions such as cell surface signaling, endocytosis and intracellular cholesterol transport. Caveolin-1 is a key protein in these domains and contributes to the organization of cholesterol and saturated lipids within these vesicular invaginations of the plasma membrane. Caveolae are thought to be involved in the signaling of tyrosine kinase receptors and serine threonine receptors. In this article… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
104
0
2

Year Published

2010
2010
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 91 publications
(113 citation statements)
references
References 40 publications
5
104
0
2
Order By: Relevance
“…BMPR-I and BMPR-II are continuously internalized mainly via the clathrin-mediated pathway mainly, while BMPR-II is also additionally endocytosed via lipid rafts (32, 64 -65). Ligand activation to preformed receptor complexes (PFCs) can induce Smad phosphorylation at the plasma membrane even before clathrin-coated pit (CCP) formation or internalization, while receptor endocytosis is required for the continuation of signal transduction and target gene expression (32,64). Internalized cell surface receptors are either recycled to the plasma membrane or transported to lysosomes for degradation (66).…”
Section: Discussionmentioning
confidence: 99%
“…BMPR-I and BMPR-II are continuously internalized mainly via the clathrin-mediated pathway mainly, while BMPR-II is also additionally endocytosed via lipid rafts (32, 64 -65). Ligand activation to preformed receptor complexes (PFCs) can induce Smad phosphorylation at the plasma membrane even before clathrin-coated pit (CCP) formation or internalization, while receptor endocytosis is required for the continuation of signal transduction and target gene expression (32,64). Internalized cell surface receptors are either recycled to the plasma membrane or transported to lysosomes for degradation (66).…”
Section: Discussionmentioning
confidence: 99%
“…Several studies suggest that several signaling cascades, including TGF-b, BMP, Wnt, and MAPK, internalize via the caveolin endocytosis to produce different outputs from those via the clathrin-dependent pathway (Di Guglielmo et al, 2003;Nohe et al, 2005;Hartung et al, 2006;Sprenger et al, 2006). Cell surface receptors, such as epidermal growth factor receptor (EGFR), is also shown to be associated with the plasma membrane microdomain, where their tyrosine kinases become inactivated (Couet et al, 1997;Waugh et al, 1999;Lajoie et al, 2007).…”
Section: Two Pathways From the Plasma Membrane To The Endosomesmentioning
confidence: 99%
“…BMP receptors are present on the cell surface in hetero-oligomeric complexes. Although there are some data indicating that BMPRI and BMPRII are segregated and localized both in clathrin coated vesicles and caveolae [30,31] recent atomic force and combined confocal microscopic results showed, that BMP2 binds with high affinity to BMP receptors localized in caveolae, and the BMPRI receptor is phosphorylated in caveolae [32]. It is known that most of the signalling molecules (receptors, tyrosine kinases etc) are inhibited when bound to caveolin-1, stimulation with specific ligands releases caveolin-1 and the signalling is initiated [33].…”
mentioning
confidence: 99%
“…It is known that most of the signalling molecules (receptors, tyrosine kinases etc) are inhibited when bound to caveolin-1, stimulation with specific ligands releases caveolin-1 and the signalling is initiated [33]. In case of BMP signalling the binding of BMPRII to caveolin-1 inhibits the phosphorylation and the activation of BMPRI in the absence of the ligand [31]. Binding of BMP-2 to its receptors, releases caveolin-1 resulting in proceeding activation of Smad signalling pathway [31].…”
mentioning
confidence: 99%